Search for: "NSE Products" Results 1 - 8 of 8
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Mar 2019, 9:56 am
In view of demutualisation generally and given the expectations from a post-demutualised NSE, here are some thoughts on the role which IP may play: a) Knowledge dissemination as products/revenue-generating activities: With their knowledge of market activities and production of quality data regarding market activities, stock exchanges are a fountain of knowledge. [read post]
8 Nov 2011, 10:11 am by Meg Kribble
The topic of research could relate to securities market micro-structure, market efficiency, new products, legal aspects related to securities market etc. [read post]
28 Feb 2012, 6:08 pm by Mark Zamora
”Globus Medical had sought clearance of its NuBone product in January 2009, but the FDA declined to clear the product after determining that it was not substantially equivalent (NSE) to legally-marketed products. [read post]
29 Mar 2013, 5:00 am by Bexis
Every now and then, an administrative law decision – usually involving the FDA – contains something that’s useful to our product liability defense practices. [read post]
2 Oct 2011, 10:44 pm by FDABlog HPM
  It then must wait for FDA to issue an NSE determination before it can file a petition for de novo classification. [read post]
4 May 2010, 6:00 am
NSE is therefore outside the purview of the RTI, at least for now. 3. [read post]
1 Mar 2011, 3:58 am by jcampbell
  At http://www.gov.ns.ca/nse/water/waterquality.asp . [read post]